Statement of Changes in Shareholders’ Deficit - USD ($)		Ordinary Shares Class A	Ordinary Shares Class B	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Jan. 30, 2024
Balance (in Shares) at Jan. 30, 2024
Issuance of Ordinary shares to Sponsor	[1],[2]		$ 844	24,156		25,000
Issuance of Ordinary shares to Sponsor (in Shares)	[1],[2]		8,433,333
Net income (loss)					(85,796)	(85,796)
Balance at Dec. 31, 2024				24,156	(85,796)	(60,796)
Balance (in Shares) at Dec. 31, 2024
Accretion for Class A ordinary shares to redemption amount				(16,847,951)	(14,080,736)	(30,928,687)
Sale of 740,000 Private Placement Units		$ 74		7,399,926		7,400,000
Sale of 740,000 Private Placement Units (in Shares)		740,000
Fair value of rights included in Public units				7,369,890		7,369,890
Allocated value of transaction costs to Class A shares				(527,875)		(527,875)
Share based compensation				2,581,854		2,581,854
Issuance of Ordinary shares to Sponsor	[1],[2]
Net income (loss)					498,416	498,416
Balance at Dec. 31, 2025		$ 74	$ 844		$ (13,668,116)	$ (13,667,198)
Balance (in Shares) at Dec. 31, 2025		740,000	8,433,333

[1] On October 10, 2024, in connection with a recapitalization, the Company issued the Sponsor an additional 1,916,667 Class B ordinary shares for no additional consideration, following which the Sponsor holds 7,666,667 Class B ordinary shares. On November 18, 2024, the Company effected a share capitalization of 766,667 Class B ordinary shares, as a result of which the Sponsor owns 8,433,333 founder shares for which it paid approximately $0.003 per share. All share amounts have been retroactively restated to reflect these adjustments.

[2] This number includes an aggregate of up to 1,100,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.